cbdMD (YCBD) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YCBD cbdMD Inc YCBD
39 GF Score
Price $0.65
GF Value $0.16
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is cbdMD 5-Year Yield-on-Cost %?

cbdMD YCBD -1.54% 39 5-Year Yield-on-Cost % is 0.00 as of Jul. 15, 2026. GuruFocus rates YCBD with a GF Score™ of 39/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 515 Drug Manufacturers companies, cbdMD ranks worse than 194174.56% on this metric.

cbdMD's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for cbdMD's 5-Year Yield-on-Cost % or its related term are showing as below:



YCBD's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.25
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

cbdMD  (AMEX:YCBD) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


cbdMD 5-Year Yield-on-Cost % Related Terms


YCBD vs AKAN, GELS, SNOA: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where cbdMD's 5-Year Yield-on-Cost % falls into.


YCBD
39GF Score
cbdMD Inc YCBD
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

cbdMD 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of cbdMD is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
cbdMD (YCBD) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on cbdMD and its competitors. According to the industry distribution chart, cbdMD ranks #999999 out of 515 companies in the Drug Manufacturers industry.
Is cbdMD's 5-Year Yield-on-Cost % too high?
cbdMD's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, cbdMD ranks #999999 out of 515 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, cbdMD has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's 5-Year Yield-on-Cost % compare to AKAN and GELS?
According to the Drug Manufacturers industry distribution chart, cbdMD ranks #999999 out of 515 companies for 5-Year Yield-on-Cost %. This places cbdMD in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.25, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on cbdMD and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. cbdMD's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.65 — trading 304.8% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. cbdMD's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For cbdMD (YCBD), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.65 is trading 304.8% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $0.16 vs. price of $0.65 (304.8% above fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
39GF Score

Get the complete analysis for YCBD

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$0.16
GF Value